A detailed history of Boothbay Fund Management, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 23,608 shares of PACB stock, worth $43,674. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,608
Holding current value
$43,674
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$1.55 - $2.65 $36,592 - $62,561
23,608 New
23,608 $43,000
Q3 2022

Nov 14, 2022

BUY
$3.93 - $8.57 $56,132 - $122,405
14,283 New
14,283 $83,000
Q2 2020

Aug 14, 2020

SELL
$2.65 - $4.03 $52,470 - $79,794
-19,800 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$2.36 - $5.26 $46,728 - $104,148
19,800 New
19,800 $61,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $416M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.